US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 91.420
  • -0.160-0.17%
Close Jul 24 16:00 ET
  • 91.420
  • 0.0000.00%
Post 16:20 ET
4.66BMarket Cap39.92P/E (TTM)

Haemonetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 30, 2024
(Q4)Mar 30, 2024
(Q3)Dec 30, 2023
(Q2)Sep 30, 2023
(Q1)Jul 1, 2023
(FY)Apr 1, 2023
(Q4)Apr 1, 2023
(Q3)Dec 31, 2022
(Q2)Oct 1, 2022
(Q1)Jul 2, 2022
Total revenue
12.01%1.31B
12.77%343.29M
10.14%336.25M
6.96%318.18M
19.08%311.33M
17.67%1.17B
14.87%304.42M
305.3M
24.01%297.49M
261.46M
Operating revenue
12.01%1.31B
12.77%343.29M
10.14%336.25M
6.96%318.18M
19.08%311.33M
17.67%1.17B
14.87%304.42M
--305.3M
24.01%297.49M
--261.46M
Cost of revenue
11.55%617.51M
12.97%167.38M
8.04%158.38M
5.78%147.67M
20.87%144.07M
13.51%553.56M
15.13%148.17M
146.59M
18.96%139.61M
119.2M
Gross profit
12.43%691.55M
12.58%175.91M
12.07%177.87M
8.00%170.51M
17.57%167.27M
21.68%615.1M
14.63%156.25M
158.71M
28.84%157.88M
142.26M
Operating expense
12.80%518.25M
21.90%147.96M
14.26%131.89M
12.27%124.79M
1.89%113.61M
5.78%459.45M
3.64%121.38M
115.43M
13.38%111.15M
111.5M
Selling and administrative expenses
14.63%431.78M
24.47%121.68M
18.01%111.71M
13.99%104.9M
1.36%93.49M
10.74%376.68M
5.78%97.76M
--94.66M
21.45%92.03M
--92.23M
Research and development costs
8.59%54.44M
1.36%15.86M
4.54%13.27M
16.24%12.67M
16.02%12.65M
7.12%50.13M
18.43%15.64M
--12.69M
0.40%10.9M
--10.9M
Depreciation amortization depletion
-1.87%32.03M
30.74%10.43M
-14.45%6.91M
-12.15%7.22M
-10.68%7.47M
-31.16%32.64M
-30.56%7.97M
--8.08M
-27.89%8.22M
--8.37M
-Depreciation and amortization
-1.87%32.03M
30.74%10.43M
-14.45%6.91M
-12.15%7.22M
-10.68%7.47M
-31.16%32.64M
-30.56%7.97M
--8.08M
-27.89%8.22M
--8.37M
Operating profit
11.34%173.3M
-19.87%27.94M
6.24%45.98M
-2.16%45.72M
74.40%53.66M
118.77%155.65M
81.64%34.87M
43.28M
90.67%46.73M
30.77M
Net non-operating interest income expense
11.02%-13.02M
-148.35%-6.53M
-84.74%-1.95M
56.44%-2.47M
60.76%-2.07M
14.55%-14.63M
32.10%-2.63M
-1.06M
-23.65%-5.67M
-5.27M
Non-operating interest expense
-11.02%13.02M
148.35%6.53M
84.74%1.95M
-56.44%2.47M
-60.76%2.07M
-14.55%14.63M
-32.10%2.63M
--1.06M
23.65%5.67M
--5.27M
Other net income (expense)
-2,303.93%-8.42M
2M
-10.42M
-96.02%382K
Special income (charges)
-2,303.93%-8.42M
423.56%2M
--0
---10.42M
----
-96.02%382K
--382K
--0
--0
----
-Less:Impairment of capital assets
--10.42M
--0
--0
--10.42M
----
--0
--0
--0
--0
----
-Gain on sale of business
423.56%2M
----
----
----
----
-96.02%382K
----
----
----
----
Income before tax
7.40%151.87M
-28.24%23.41M
4.27%44.03M
-20.04%32.83M
102.36%51.59M
122.23%141.4M
112.87%32.63M
42.22M
106.10%41.06M
25.49M
Income tax
31.94%34.31M
-6.04%3.05M
37.80%12.79M
0.79%7.92M
87.79%10.55M
28.38%26M
-41.94%3.24M
9.28M
55.19%7.86M
5.62M
Net income
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
166.05%115.4M
201.64%29.38M
32.94M
123.46%33.2M
19.88M
Net income continuous Operations
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
166.05%115.4M
201.64%29.38M
--32.94M
123.46%33.2M
--19.88M
Minority interest income
Net income attributable to the parent company
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
166.05%115.4M
201.64%29.38M
32.94M
123.46%33.2M
19.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1.87%117.56M
-30.68%20.37M
-5.17%31.24M
-24.97%24.91M
106.48%41.04M
166.05%115.4M
201.64%29.38M
32.94M
123.46%33.2M
19.88M
Basic earnings per share
2.20%2.32
-31.15%0.401
-4.62%0.62
-24.62%0.49
107.69%0.81
167.06%2.27
205.65%0.5825
0.65
124.14%0.65
0.39
Diluted earnings per share
2.23%2.29
-29.82%0.4
-4.69%0.61
-25.00%0.48
110.53%0.8
166.67%2.24
200.00%0.57
0.64
120.69%0.64
0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Mar 30, 2024(Q4)Mar 30, 2024(Q3)Dec 30, 2023(Q2)Sep 30, 2023(Q1)Jul 1, 2023(FY)Apr 1, 2023(Q4)Apr 1, 2023(Q3)Dec 31, 2022(Q2)Oct 1, 2022(Q1)Jul 2, 2022
Total revenue 12.01%1.31B12.77%343.29M10.14%336.25M6.96%318.18M19.08%311.33M17.67%1.17B14.87%304.42M305.3M24.01%297.49M261.46M
Operating revenue 12.01%1.31B12.77%343.29M10.14%336.25M6.96%318.18M19.08%311.33M17.67%1.17B14.87%304.42M--305.3M24.01%297.49M--261.46M
Cost of revenue 11.55%617.51M12.97%167.38M8.04%158.38M5.78%147.67M20.87%144.07M13.51%553.56M15.13%148.17M146.59M18.96%139.61M119.2M
Gross profit 12.43%691.55M12.58%175.91M12.07%177.87M8.00%170.51M17.57%167.27M21.68%615.1M14.63%156.25M158.71M28.84%157.88M142.26M
Operating expense 12.80%518.25M21.90%147.96M14.26%131.89M12.27%124.79M1.89%113.61M5.78%459.45M3.64%121.38M115.43M13.38%111.15M111.5M
Selling and administrative expenses 14.63%431.78M24.47%121.68M18.01%111.71M13.99%104.9M1.36%93.49M10.74%376.68M5.78%97.76M--94.66M21.45%92.03M--92.23M
Research and development costs 8.59%54.44M1.36%15.86M4.54%13.27M16.24%12.67M16.02%12.65M7.12%50.13M18.43%15.64M--12.69M0.40%10.9M--10.9M
Depreciation amortization depletion -1.87%32.03M30.74%10.43M-14.45%6.91M-12.15%7.22M-10.68%7.47M-31.16%32.64M-30.56%7.97M--8.08M-27.89%8.22M--8.37M
-Depreciation and amortization -1.87%32.03M30.74%10.43M-14.45%6.91M-12.15%7.22M-10.68%7.47M-31.16%32.64M-30.56%7.97M--8.08M-27.89%8.22M--8.37M
Operating profit 11.34%173.3M-19.87%27.94M6.24%45.98M-2.16%45.72M74.40%53.66M118.77%155.65M81.64%34.87M43.28M90.67%46.73M30.77M
Net non-operating interest income expense 11.02%-13.02M-148.35%-6.53M-84.74%-1.95M56.44%-2.47M60.76%-2.07M14.55%-14.63M32.10%-2.63M-1.06M-23.65%-5.67M-5.27M
Non-operating interest expense -11.02%13.02M148.35%6.53M84.74%1.95M-56.44%2.47M-60.76%2.07M-14.55%14.63M-32.10%2.63M--1.06M23.65%5.67M--5.27M
Other net income (expense) -2,303.93%-8.42M2M-10.42M-96.02%382K
Special income (charges) -2,303.93%-8.42M423.56%2M--0---10.42M-----96.02%382K--382K--0--0----
-Less:Impairment of capital assets --10.42M--0--0--10.42M------0--0--0--0----
-Gain on sale of business 423.56%2M-----------------96.02%382K----------------
Income before tax 7.40%151.87M-28.24%23.41M4.27%44.03M-20.04%32.83M102.36%51.59M122.23%141.4M112.87%32.63M42.22M106.10%41.06M25.49M
Income tax 31.94%34.31M-6.04%3.05M37.80%12.79M0.79%7.92M87.79%10.55M28.38%26M-41.94%3.24M9.28M55.19%7.86M5.62M
Net income 1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M166.05%115.4M201.64%29.38M32.94M123.46%33.2M19.88M
Net income continuous Operations 1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M166.05%115.4M201.64%29.38M--32.94M123.46%33.2M--19.88M
Minority interest income
Net income attributable to the parent company 1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M166.05%115.4M201.64%29.38M32.94M123.46%33.2M19.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1.87%117.56M-30.68%20.37M-5.17%31.24M-24.97%24.91M106.48%41.04M166.05%115.4M201.64%29.38M32.94M123.46%33.2M19.88M
Basic earnings per share 2.20%2.32-31.15%0.401-4.62%0.62-24.62%0.49107.69%0.81167.06%2.27205.65%0.58250.65124.14%0.650.39
Diluted earnings per share 2.23%2.29-29.82%0.4-4.69%0.61-25.00%0.48110.53%0.8166.67%2.24200.00%0.570.64120.69%0.640.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg